article Articles

Site Empowerment Starts with Enhanced Communication

Site empowerment aims to improve the relationship between sites and their sponsors. Successful site-sponsor relationships all come down to establishing and upholding clear communication.

Virtual Trials and the Site’s Role in a Shifting Research Landscape

Virtual trials have grown in popularity and usage over the last decade. Explore what that means for traditional sites and their future in the clinical research landscape.

4 Valuable Integrations for Your Clinical Trial Management System

Implementing and integrating a CTMS can be beneficial for your organization. Streamline your research operations with these 4 integrations.

How to Get Buy-in for a Participant Payment System

Key tips to prepare for objections, involve multiple stakeholders and gain leadership approval.

Spring 2020 Onsemble Conference: 6 Can’t-Miss Sessions

Registration for Spring 2020 Onsemble is now open. Thinking of attending? Check out 6 can’t-miss sessions.

Understanding the Types of FDA Inspections

Receiving notice of an FDA audit can be stressful for an organization. Breaking down the different types of inspections, here’s what you can expect upon each announcement.

Cancer Community Activation Timelines: Are NCI Expectations Achievable?

The NCI sets high standards for protocol activation timelines. While the expectation for protocols to be activated in 8-12 weeks, is it achievable? What can be done to improve study start up time?

Establishing Change Management in the Workplace

While change is bound to happen in any workplace, there are steps organizations can take to ease the transition. Learn more about common practices to implement in your organization.

Waiving Informed Consent Under the Proposed Rule

Under the Proposed Rule, minimal risk trials may have the ability to waive informed consent. Explore the benefits and challenges of this rule.

To Pay or Not to Pay: The Ethics of Participant Payments

Should participants be paid for clinical trials or not? A look at ethics literature.

Q&A Part II: How Protocol Feasibility Assists in Promoting Compliance

In this Q&A, Dr. Wendy Tate answers attendee questions from her webinar “How Protocol Feasibility Assists in Promoting Compliance.”

Forte’s Top 10 Clinical Research Resources of 2019

We strive to create meaningful and relevant content for the clinical research industry. Check out our top 10 resources of 2019.

1 4 5 6 7 8 37